Catch up on the top radiology content of the past week.
|Articles|November 10, 1999
CTI, Mobile PET launch European PET unit
CTI PET Systems (CPS), the joint venture between CTI and Siemens Nuclear Medicine Group, has expanded its partnership with Mobile PET Systems. The two companies announced last month the launch of a mobile PET operation that will serve European hospitals.
Advertisement
CTI PET Systems (CPS), the joint venture between CTI and Siemens Nuclear Medicine Group, has expanded its partnership with Mobile PET Systems. The two companies announced last month the launch of a mobile PET operation that will serve European hospitals. Knoxville, TN-based CPS will provide an ECAT PET scanner.
Sparked by Mobile PET Systems successful debut of mobile PET services at the October European Association of Nuclear Medicine meeting in Barcelona, Spain, the deal makes San Diego, CA-based Mobile PET the first company to provide mobile ECAT PET imaging technology in Europe, the two firms said. Mobile PET expects to begin service within the next three months through Mobile PET Systems Europe, a joint venture it formed with Neuromed of Germany.
The deal adds to the momentum Mobile PET has been enjoying since December 1998 when the company went public, bolstered by a favorable reimbursement market for PET. In February, the firm bought five mobile coaches from Calumet Coach of Calumet City, IL, expanding its service capability, and in March, received a $10 million line of credit from Finova Capital, which it has used to cover the purchase of five Siemens ECAT Exact PET cameras (SCAN 2/17/99 and 3/31/99).
Advertisement
Related to this article
Catch up on the top radiology content of the past week.
While a new article raises provocative questions about the capability of photon-counting CT (PCCT) to perhaps replace diagnostic ICA, the real revolution with this modality is going beyond stenosis measurement to a renewed focus on the disease of atherosclerosis.
The use of adjunctive CT bone reading software in women with breast cancer detected between 8 to 22 percent more metastatic lesions for reviewing radiologists and reduced CT interpretation time by 50 percent or more, according to a new study.
How will generative AI software be evaluated by the FDA in the future? What’s next for point-of-care ultrasound? What steps have been successful in facilitating adoption of AI applications across enterprise systems? Leaders in radiology and health care will be discussing these topics and more at the upcoming HLTH USA conference.
Catch up on the top radiology content of the past week.
In the third of a three-part podcast episode, Wendie Berg, MD, PhD, FACR, FSBI, Manisha Bahl, MD, and Amy Patel, MD discuss recent developments with autonomous AI in breast imaging and share their perspective on the overall potential of AI to help mitigate the radiologist shortage.
In the second of a three-part podcast episode, Wendie Berg, MD, PhD, FACR, FSBI, Manisha Bahl, MD, and Amy Patel, MD discuss how to handle disagreements with adjunctive AI in breast imaging, whether to include AI assessments in PACS, and whether patients should pay for the use of adjunctive AI.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
FDA Clears MRI-Based AI Software for Prognostic Evaluation of Patients with Mild Cognitive Impairment
2
Can MRI-Based AI Have an Impact in Reducing Unnecessary Prostate Biopsies?
3
The Reading Room Podcast: A Closer Look at New Research on 177Lu-Edotreotide for Treating GEP-NETs
4
How AI, Theranostics and More Empowered Patients Have Led to Significant Changes in Radiology
5